Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000899243-22-031430

Chief Executive Officer sold 1,350 shares at $7.26 ($9,801)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2022-09-16 Sale −1,350 $7.26 $9,801 254,784 D
Open-market sales · 1,350 sh · avg $7.26 · $9,801
Loading xslF345X03/doc4.xml…